FDA Inspection
Chartwell Pharmaceuticals LLCChartwell Pharmaceuticals LLC – FDA Inspection, Dec 19, 2024
Record Details
This FDA Inspection record concerns Chartwell Pharmaceuticals LLC, with an inspection on December 19, 2024, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 5e708f24-2e9e-4c56-8797-4d6e0fdc2511
Inspection Facts
- Inspection number
- 1257321
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.176Failing to test for penicillin cross-contamination
- 21 CFR 211.186(b)(2)Active Ingredient Name and Weight
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Chartwell Pharmaceuticals LLC
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2025 | OAI | New York District Office | Drug Quality Assurance |
| May 31, 2024 | OAI | New York District Office | Generic Drug Evaluation |
| April 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 24, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chartwell Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.